|Mr. Tom Y. Lee||CEO, Pres & Chairman||52k||N/A||1949|
|Mr. Mark Stuart Elliott||VP of Fin. and Principal Financial & Accounting Officer||180k||N/A||1975|
|Mr. Thomas Richard Myers||Chief Operating Officer||200k||N/A||1952|
|Ms. Bridget C. Tinsley-Cormier M.S.||Sr. VP of Technology & Bus. Devel. and VP of Market Devel.||N/A||N/A||N/A|
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate that is used to clean stainless steel equipment, resilient floors, walls, and painted surfaces. Its SDC-based disinfecting and sanitizing products comprise Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial solution that is used against bacteria, viruses, yeasts, and molds. The company was founded in 1992 and is headquartered in Rancho Cucamonga, California.
PURE Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.